Skip to main content
. Author manuscript; available in PMC: 2016 Apr 19.
Published in final edited form as: JAMA Neurol. 2015 Feb;72(2):180–186. doi: 10.1001/jamaneurol.2014.2956

Figure 3. Cerebrospinal Fluid (CSF) C-X-C Motif Chemokine (CXCL13) Concentration Correlates With the Magnitude of Intrathecal Synthesis of N-Methyl-D-Aspartate Receptor (NMDAR) Antibodies.

Figure 3

Concentration of CSF CXCL13 is plotted against the intrathecal NMDAR-antibody synthesis in the first available CSF sample (onset of neurological symptoms to sample: median, 1.6 months [interquartile range, 0.5–3.6 months]) of patients with monophasic anti-NMDAR encephalitis (n = 24). Pearson R2 and significance P value indicated. For graphical reasons, CSF CXCL13 concentrations below 1 pg/mL are depicted as negative (Neg).